Login to Your Account



Patient dies in phase I trial of Bial pain drug

By Nuala Moran
Staff Writer

Tuesday, January 19, 2016

LONDON – A volunteer who was taken ill in the phase I trial of BIA 10-2474 – designed to target pain relief by acting on cannabinoid receptors – has died, according to Bial-Portela & Ca. SA, while five others remain hospitalized.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription